Skip to main content
Caplight Logo









Livance

Livance

Private
São PauloHealthcare & Life Scienceshttps://livance.com.br/

Last Round

Series B

Nov 28, 2023

Total Funding Raised

$19.27M

Company Overview

Livance is a healthtech company that provides a space-as-a-service platform offering flexible, pay-per-use medical office spaces and practice management solutions for healthcare professionals.

Sector

Healthcare & Life Sciences

Verticals

Co-working Spaces, Vertical SaaS, Facility Management

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

space-as-a-servicemedical coworkingpay-per-use officepractice management softwaremedical office rentalhealthtechvertical SaaSclinic managementproptechusage-based billingdigital receptionmedical infrastructurescheduling softwareflexible office spacehealthcare operations

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Livance Comparables

Compare Livance with similar companies based on industry and business-model similarity.

Livance comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nexus Espaço Saúde
78%
Praktes Health
74%
East Clinic Consultórios
71%

Livance Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 28, 2023
Series AJul 1, 2021
SeedJul 22, 2020

Key People

Founding team and executive leadership

Claudio Mifano

Co-Founder and CEO

Founding Team

Fernandah Monte

Fisioterapeuta e biomedica no CEO corporate - barra da tijuca

Executive Team

Rodrigo Baeta Neves

CFO e Head de Expansão

Executive Team

Livance Investors

Notable investors and investment history

Livance investors
InvestorRounds
Terracotta VenturesSeries A, Series B
Cadonau InvestimentosSeries B, Series A
Green RockSeries A
MonasheesSeries B
Mago CapitalSeries A
AstellaSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 28, 2023

    $13.3M round led by Monashees.

  • Jul 1, 2021

    $6M round led by Cadonau Investimentos and Astella.

Livance Filings

Explore SEC and related filing metadata, where available.

Livance filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Livance's valuation, stock price, and market status.

Is Livance a public or private company?

Livance is a private company.

What is the current stock price of Livance?

Livance is a private company with no public stock price. No recent secondary market data is available.

How much is Livance worth (valuation)?

Valuation information for Livance is not publicly available.

Can I buy Livance stock?

Livance shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Livance's last funding round?

Livance's most recent funding round was Series B on November 28, 2023.

Who are the main investors in Livance?

Key investors in Livance include Cadonau Investimentos, Monashees, Astella.

Will Livance IPO soon?

No public IPO plans have been announced for Livance.

How can I track Livance secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Livance's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSão Paulo
Employee Range450
Year Founded2017
Last FundingNov 28, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?